Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 57Terminated 23Recruiting 8Withdrawn 6Active not recruiting 5Unknown 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Thoracic 1

Conditions

Neuroblastoma 3Melanoma 3Uterine Cervical Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma, Non-Hodgkin 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Solid Tumor 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma 1Anus Neoplasms 1Advanced Refractory Solid Tumors 1Advanced Malignant Solid Tumor 1

Interventions

Nivolumab 23pembrolizumab 19Ipilimumab 13toripalimab 12Temozolomide 11Biopsy 8Dacarbazine 7Blood Specimen Collection 6trametinib 5dabrafenib 5camrelizumab 5atezolizumab 5Gene Expression Profiling 5Cyclophosphamide 5Chemotherapy, Adjuvant 5fludarabine 4durvalumab 4binimetinib 4aldesleukin 4Injections 4tislelizumab 3palbociclib 3encorafenib 3apatinib 3Sorafenib 3Introns 3Interleukin-2 3Drug Therapy 3Cisplatin 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Melanoma × Interleukin-2 × Clear all
NCT05798546 2023-04-04

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

BGI, China

Phase 1 Unknown
21 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT01946373 2022-10-04

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Karolinska University Hospital

Phase 1 Unknown
20 enrolled
Dermatologic

Melanoma

NCT03374839 2022-05-06

Nivo-TIL

Nantes University Hospital

Phase 1/2 Unknown
11 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡